Lilly invests further in Irish manufacturing
This article was originally published in Scrip
Executive Summary
Ireland's export market, which anticipates taking a significant hit in the coming year as a number of pharmaceuticals manufactured on its shores come off patent, has had some good news. Lilly, which already has a significant manufacturing presence in the country, announced this week that it intends to invest €330 million in building a brand new facility at its Kinsale, Cork site.